Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment

Retrieved on: 2021-05-14 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment. View article details on hiswai:

Excerpt

US medical device company Vesalio has announced the start of enrolment ... (IDE) clinical trial to utilise its NeVa thrombectomy technology platform.

Article found on: neuronewsinternational.com